Articles - 2j0f mentioned but not cited (4)
- Structures of native human thymidine phosphorylase and in complex with 5-iodouracil. Mitsiki E, Papageorgiou AC, Iyer S, Thiyagarajan N, Prior SH, Sleep D, Finnis C, Acharya KR. Biochem Biophys Res Commun 386 666-670 (2009)
- Structural basis for non-competitive product inhibition in human thymidine phosphorylase: implications for drug design. El Omari K, Bronckaers A, Liekens S, Pérez-Pérez MJ, Balzarini J, Stammers DK. Biochem J 399 199-204 (2006)
- Expression and Retention of Thymidine Phosphorylase in Cultured Reticulocytes as a Novel Treatment for MNGIE. Meinders M, Shoemark D, Dobbe JGG, Streekstra GJ, Frayne J, Toye AM. Mol Ther Methods Clin Dev 17 822-830 (2020)
- Engineering of the Recombinant Expression and PEGylation Efficiency of the Therapeutic Enzyme Human Thymidine Phosphorylase. Karamitros CS, Somody CM, Agnello G, Rowlinson S. Front Bioeng Biotechnol 9 793985 (2021)
Reviews citing this publication (5)
- The dual role of thymidine phosphorylase in cancer development and chemotherapy. Bronckaers A, Gago F, Balzarini J, Liekens S. Med Res Rev 29 903-953 (2009)
- Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy. Liekens S, Bronckaers A, Pérez-Pérez MJ, Balzarini J. Biochem Pharmacol 74 1555-1567 (2007)
- Binding isotope effects: boon and bane. Schramm VL. Curr Opin Chem Biol 11 529-536 (2007)
- Thymidine Phosphorylase in Cancer; Enemy or Friend? Elamin YY, Rafee S, Osman N, O Byrne KJ, Gately K. Cancer Microenviron 9 33-43 (2016)
- Thymidine phosphorylase: A potential new target for treating cardiovascular disease. Li W, Yue H. Trends Cardiovasc Med 28 157-171 (2018)
Articles citing this publication (8)
- Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agents. Shahzad SA, Yar M, Bajda M, Jadoon B, Khan ZA, Naqvi SA, Shaikh AJ, Hayat K, Mahmmod A, Mahmood N, Filipek S. Bioorg Med Chem 22 1008-1015 (2014)
- Identification of aspartic acid-203 in human thymidine phosphorylase as an important residue for both catalysis and non-competitive inhibition by the small molecule "crystallization chaperone" 5'-O-tritylinosine (KIN59). Bronckaers A, Aguado L, Negri A, Camarasa MJ, Balzarini J, Pérez-Pérez MJ, Gago F, Liekens S. Biochem Pharmacol 78 231-240 (2009)
- 3'-Azidothymidine in the active site of Escherichia coli thymidine phosphorylase: the peculiarity of the binding on the basis of X-ray study. Timofeev V, Abramchik Y, Zhukhlistova N, Muravieva T, Fateev I, Esipov R, Kuranova I. Acta Crystallogr D Biol Crystallogr 70 1155-1165 (2014)
- Structure analysis of archaeal AMP phosphorylase reveals two unique modes of dimerization. Nishitani Y, Aono R, Nakamura A, Sato T, Atomi H, Imanaka T, Miki K. J Mol Biol 425 2709-2721 (2013)
- The kinetic mechanism of Human Thymidine Phosphorylase - a molecular target for cancer drug development. Deves C, Rostirolla DC, Martinelli LK, Bizarro CV, Santos DS, Basso LA. Mol Biosyst 10 592-604 (2014)
- Crystal structure of pyrimidine-nucleoside phosphorylase from Bacillus subtilis in complex with imidazole and sulfate. Balaev VV, Prokofev II, Gabdoulkhakov AG, Betzel C, Lashkov AA. Acta Crystallogr F Struct Biol Commun 74 193-197 (2018)
- Pilot study investigating the prognostic significance of thymidine phosphorylase expression in patients with metastatic breast cancer: a single institution retrospective analysis. Tedeschi AL, Eslami Z, Garoufalis E, Saleh RR, Omeroglu A, Altinel G, Ait-Tihyaty M, Jean-Claude B, Mihalcioiu C. Onco Targets Ther 8 911-919 (2015)
- Polycyclic nitrogen heterocycles as potential thymidine phosphorylase inhibitors: synthesis, biological evaluation, and molecular docking study. Aknin K, Bontemps A, Farce A, Merlet E, Belmont P, Helissey P, Chavatte P, Sari MA, Giorgi-Renault S, Desbène-Finck S. J Enzyme Inhib Med Chem 37 252-268 (2022)